Back

Evaluating myocardial involvement in patients with multiple myeloma at different stages a cardiac MR T1 mapping study

1 September 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: Characterisation of cardiomyopathies with cardiac magnetic resonance Myocardial Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Sir Peihong Guo

1st Affiliated Hospital of Kunming Medical University, Kunming (China)

7 More presentations in this session

Presentation thumbnail
Imaging predictors of adverse prognosis in fabry disease cardiomyopathy: a systematic review and meta-analysis
Mr T. Rojanathagoon (University Of Bristol, GB)
Abstract Slides Video
Presentation thumbnail
Left atrial strain predicts adverse events in hypertrophic cardiomyopathy: preliminary results from a CMR study
Doctor F. Gonzalez-Santorum (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Comparative assessment of extracellular volume metrics in predicting adverse outcomes in patients with transthyretin amyloid cardiomyopathy
Doctor C. Kronberger (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Study design of the CARDIO-TTRansform cardiac magnetic resonance imaging substudy
Professor M. Fontana (London, GB)
Abstract Slides Video
Presentation thumbnail
Myocardial determinants of Functional limitation in advanced Fabry cardiomyopathy
Doctor G. Guida (San Donato Milanese, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Characterisation of cardiomyopathies with cardiac magnetic resonance

The Event

Event poster

ESC Congress 2024

1 September 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Heart failure in patients with multiple myeloma: need for a multiparametric approach
21 May 2023
thumbnail
Congress Presentation
Prospective evaluation of cardiac function following anti-BCMA CAR-T therapy in multiple myeloma
21 June 2025
thumbnail
Congress Presentation
Longitudinal changes of cardiac magnetic resonance parameters in patients with cardiac light-chain amyloidosis receiving anti-plasma cell therapy
29 August 2025
thumbnail
Congress Presentation
How to do parametric mapping
11 December 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources